1. Home
  2. REFI vs RZLT Comparison

REFI vs RZLT Comparison

Compare REFI & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFI
  • RZLT
  • Stock Information
  • Founded
  • REFI 2021
  • RZLT 2010
  • Country
  • REFI United States
  • RZLT United States
  • Employees
  • REFI N/A
  • RZLT N/A
  • Industry
  • REFI Real Estate Investment Trusts
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • REFI Real Estate
  • RZLT Health Care
  • Exchange
  • REFI Nasdaq
  • RZLT Nasdaq
  • Market Cap
  • REFI 293.5M
  • RZLT 361.3M
  • IPO Year
  • REFI 2021
  • RZLT N/A
  • Fundamental
  • Price
  • REFI $13.70
  • RZLT $5.11
  • Analyst Decision
  • REFI Strong Buy
  • RZLT Strong Buy
  • Analyst Count
  • REFI 3
  • RZLT 6
  • Target Price
  • REFI $20.00
  • RZLT $12.00
  • AVG Volume (30 Days)
  • REFI 109.1K
  • RZLT 1.5M
  • Earning Date
  • REFI 08-06-2025
  • RZLT 05-13-2025
  • Dividend Yield
  • REFI 13.71%
  • RZLT N/A
  • EPS Growth
  • REFI N/A
  • RZLT N/A
  • EPS
  • REFI 1.88
  • RZLT N/A
  • Revenue
  • REFI $56,790,054.00
  • RZLT N/A
  • Revenue This Year
  • REFI $15.53
  • RZLT $35.39
  • Revenue Next Year
  • REFI $6.70
  • RZLT N/A
  • P/E Ratio
  • REFI $7.29
  • RZLT N/A
  • Revenue Growth
  • REFI 4.68
  • RZLT N/A
  • 52 Week Low
  • REFI $12.76
  • RZLT $2.22
  • 52 Week High
  • REFI $16.47
  • RZLT $6.19
  • Technical
  • Relative Strength Index (RSI)
  • REFI 36.24
  • RZLT 65.73
  • Support Level
  • REFI $13.85
  • RZLT $4.15
  • Resistance Level
  • REFI $14.15
  • RZLT $5.44
  • Average True Range (ATR)
  • REFI 0.26
  • RZLT 0.30
  • MACD
  • REFI -0.03
  • RZLT 0.05
  • Stochastic Oscillator
  • REFI 1.11
  • RZLT 75.00

About REFI Chicago Atlantic Real Estate Finance Inc.

Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Share on Social Networks: